Picture EBD Group World of Partnering Opportunities 650x100px
Organisation › Details

Kreaxi (Group)

Formed by the merger of Rhône-Alpes Création and Banexi Ventures Partners, KREAXI is one of the French leaders in venture capital, totaling over €500 million ($540M) in funding raised from public and private investors. Launched in 1989, KREAXI’s regional activity has accompanied over 280 Auvergne-Rhône-Alpes companies – with recent successes such as Erytech Pharma, Nanobiotix, Amoeba, PX Therapeutics or Docea Power – taking a stake at an early stage to finance their initial development phases. With €69 million ($74.5M) in funds under management thanks to the support of the Auvergne-Rhône-Alpes region, Bpifrance, regional banks and industrial groups, Kreaxi plays a key role in financing seed and creation phases. It manages a portfolio of around fifty shareholdings through its three funds (RAC I, RAC II and R2V), with an active staff of nine. *


Period Start 2017-03-28 merged before
Products Industry venture capital
  Industry 2 LIFE SCIENCES
Region Region Paris
  Country France
  Street 13–15 rue Taitbout
  City 75009 Paris
  Tel +33-1-7302-8969
    Address record changed: 2024-01-05
Basic data Employees n. a.
  Currency EUR
  Annual sales 500,000,000 (funds, managed (2017) 2017-03-28)
    * Document for »About Section«: Apix Analytics S.A.. (12/1/17). "Press Release: Apix Analytics Raises 8 Million Euros to Accelerate Its International Development". Grenoble.
Record changed: 2024-02-12


Picture Consultech GmbH Secure Funding with RnD Grants 650x200px

To subscribe to our free, monthly mass spectrometry newsletter, please send an e-mail to and simply fill the subject line with the word »MSC Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]

Please visit also our web portals for the Eurpean life sciences and the life sciences in German-speaking Europe (DE, AT & CH) at and


Picture EBD Group World of Partnering Opportunities 650x300px

» top